Abstract:Introduction Recently, several genome-wide association studies (GWAS) have identified novel single nucleotide polymorphisms (SNPs) associated with breast cancer risk. However, most of the studies were conducted among Caucasians and only one from Chinese. Methods In the current study, we first tested whether 15 SNPs identified by previous GWAS were also breast cancer marker SNPs in this Chinese population. Then, we grouped the marker SNPs, and modeled them with clinical risk factors, to see the usage of these factors in breast cancer risk assessment. Two methods (risk factors counting and odds ratio (OR) weighted risk scoring) were used to evaluate the cumulative effects of the five significant SNPs and two clinical risk factors (age at menarche and age at first live birth). Results Five SNPs located at 2q35, 3p24, 6q22, 6q25 and 10q26 were consistently associated with breast cancer risk in both testing set (878 cases and 900 controls) and validation set (914 cases and 967 controls) samples. Overall, all of the five SNPs contributed to breast cancer susceptibility in a dominant genetic model (2q35, rs13387042: adjusted OR = 1.26, P = 0.006; 3q24.1, rs2307032: adjusted OR = 1.24, P = 0.005; 6q22.33, rs2180341: adjusted OR = 1.22, P = 0.006; 6q25.1, rs2046210: adjusted OR = 1.51, P = 2.40 × 10 -8 ; 10q26.13, rs2981582: adjusted OR = 1.31, P = 1.96 × 10 -4 ). Risk score analyses (area under the curve (AUC): 0.649, 95% confidence interval (CI): 0.631 to 0.667; sensitivity = 62.60%, specificity = 57.05%) presented better discrimination than that by risk factors counting (AUC: 0.637, 95% CI: 0.619 to 0.655; sensitivity = 62.16%, specificity = 60.03%) ( P < 0.0001). Absolute risk was then calculated by the modified Gail model and an AUC of 0.658 (95% CI = 0.640 to 0.676) (sensitivity = 61.98%, specificity = 60.26%) was obtained for the combination of five marker SNPs, age at menarche and age at first live birth. Conclusions This study shows that five GWAS identified variants were also consistently validated in this Chinese population and combining these genetic variants with other risk factors can improve the risk predictive ability of breast cancer. However, more breast cancer associated risk variants should be incorporated to optimize the risk assessment.

Rare Coding Variants and Breast Cancer Risk: Evaluation of Susceptibility Loci Identified in Genome-Wide Association Studies

Evaluation of Breast Cancer Susceptibility Loci in Chinese Women.

Discovery of Rare Coding Variants in OGDHL and BRCA2 in Relation to Breast Cancer Risk in Chinese Women.

Low‐frequency Nonsynonymous Variants in FKBPL and ARPC1B Genes Are Associated with Breast Cancer Risk in Chinese Women

A Comprehensive cis-eQTL Analysis Revealed Target Genes in Breast Cancer Susceptibility Loci Identified in Genome-wide Association Studies.

luation of Breast Cancer Susceptibility Loci in B & P nese Women

The Association of CASC16 Variants with Breast Cancer Risk in a Northwest Chinese Female Population

Breast Cancer Risk Assessment with Five Independent Genetic Variants and Two Risk Factors in Chinese Women

Genome-wide Association Study in East Asians Identifies Novel Susceptibility Loci for Breast Cancer.

Identification of novel susceptibility markers for the risk of overall breast cancer as well as subtypes defined by hormone receptor status in the Chinese population

Evaluating Genetic Variants Associated with Breast Cancer Risk in High and Moderate-Penetrance Genes in Asians

Low-frequency Coding Variants at 6p21.33 and 20q11.21 Are Associated with Lung Cancer Risk in Chinese Populations.

Exome sequencing identifies breast cancer susceptibility genes and defines the contribution of coding variants to breast cancer risk

Evaluation of Functional Genetic Variants for Breast Cancer Risk: Results from the Shanghai Breast Cancer Study

Breast cancer association studies in a Han Chinese population using 10 European-ancestry-associated breast cancer susceptibility SNPs

Association of Multiple Genetic Variants with Breast Cancer Susceptibility in the Han Chinese Population

Association of polymorphisms in <i>LOC105377871</i> and <i>CASC16</i> with breast cancer in the northwest Chinese Han population

Common Genetic Determinants of Breast-Cancer Risk in East Asian Women: a Collaborative Study of 23 637 Breast Cancer Cases and 25 579 Controls

Evaluation of Functional Genetic Variants at 6q25.1 and Risk of Breast Cancer in a Chinese Population

Genetic Variants at 1p11.2 and Breast Cancer Risk: A Two-Stage Study in Chinese Women

Coding Variants in the PCNT and CEP295 Genes Contribute to Breast Cancer Risk in Chinese Women.